Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (707)	5/14/2001 11:55:00 AM
From: Skywatcher	Respond to of 810

That's the reason we are falling so hard from the 11's.... the good news today is not helping as the fundies have to get rid of some shares I am sure. WASHINGTON (Dow Jones)--Nasdaq will remove 16 companies and add seven to its Biotechnology Index May 21, dropping the total to 66. In a press release Monday, Nasdaq said it will remove the following companies: Corixa Corp. (CRXA), Corvas International Inc. (CVAS), Dendreon Corp. (DNDN), DUSA Pharmaceuticals Inc. (DUSA), Exelixis Inc. (EXEL), Generex Biotechnology Corp. (GNBT), Isis Pharmaceuticals Inc. (ISIP), Kos Pharmaceuticals Inc. (KOSP), Lexicon Genetics Inc. (LEXG), Ligand Pharmaceuticals Inc. (LGND), Matrix Pharmaceuticals Inc. (MATX), Onyx Pharmaceuticals Inc. (ONXX), Progenics Pharmaceuticals Inc. (PGNX), Ribozyme Pharmaceuticals Inc. (RZYM), Sangamo BioSciences Inc. (SGMO) and Vical Inc. (VICL) Bad timing just when we were having a nice run there...guess it's back into the low 9's high 8's until this is over. at least we had some decent but not outstanding news today....that may be helping to soften the blow chris